Right ventricular afterload predicts long-term transition from parenteral to oral treprostinil in pulmonary arterial hypertension
Sign Up to like & getrecommendations! Published in 2018 at "Pulmonary Circulation"
DOI: 10.1177/2045894018797270
Abstract: Despite the increasing trends, reports on long-term follow-up are limited on transitioning from parenteral to oral treprostinil therapy in patients with pulmonary arterial hypertension (PAH). We investigated both the effectiveness of parenteral to oral treprostinil… read more here.
Keywords: oral treprostinil; transition; parenteral oral; transition transition ... See more keywords
Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14050989
Abstract: Liposomal amphotericin B (AmB) or AmBisome® is the most effective and safe therapeutic agent for visceral leishmaniasis (VL), but its clinical efficacy is limited in cutaneous leishmaniasis (CL) and HIV/VL co-infection. The aim of this… read more here.
Keywords: parenteral oral; oral routes; leishmaniasis parenteral; cutaneous leishmaniasis ... See more keywords